Drug Side Effects, Toxicities, and Interactions

Slides:



Advertisements
Similar presentations
TB & HIV Infection: Treatment
Advertisements

TB & HIV Infection: Treatment Your name Institution/organization Meeting Date International Standard 8, 13 TB & HIV Infection: Treatment Your name Institution/organization.
In The Name of God. Common Adverse Reactions to Anti-TB Drugs.
Homework/Recap Review the flipchart for the whole process of pre and post testing (pink section). Write down exactly which pages you would go to for counselling.
KITSO AIDS Training Program
VAQ 8 - Paracetamol Jon Dowling Andre Vanzyl. Question A 22 year old male presents with abdominal pain and vomiting. He states that it all started the.
Unit 8: Complications and Special Situations Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Module 2: TREATMENT.
Case Discussion: Cell Injury At the end of the Case Discussion, the involved group is requested to submit a report of answers to all the questions asked.
IMCI Dr. Bulemela Janeth (Mmed. Pead) 1IMCI for athens.
Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Infectious Diseases.
Nurses SOAR! Training Curricula Series For More Information and Inquiries:
TRICHOMONIASIS. Quick Facts Caused by a parasite that spreads during sexual contact affecting both genders Symptoms show up 5-28 days after contact May.
 Chlamydia Trachomatis Bacterium Infection  Women › a minor increase in vaginal discharge caused by an inflamed cervix. › cystitis (an inflammation.
An important message to blood donors Please read this BEFORE you donate blood.
1 Side Effects of Anti-retroviral Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Adverse Reactions & Antiretroviral Therapy Kirsten B. Balano, PharmD October 26, 2002.
1 Hepatic Toxicity in Patients Taking ARVs HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Introduction to ARV therapy
Vaccination Essay Due TODAY. No Exceptions. No, I cannot print off your paper. Turn in any Disease Charts and Ch. 23 voc. Ch. 24 Notes Today! BYOD Tomorrow.
Programme Case Studies
1 Dermatological Toxicities of ART HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Pharmacokinetics and Drug Interactions HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Monitoring treatment and changing therapy Monitoring treatment Patients on ART need close monitoring to assess:  Adherence to the prescribed regimen 
1 Guidance on Cotrimoxazole Prophylactic Therapy for HIV Exposed/Infected Children HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV is the virus that causes AIDS, a disease that weakens the body’s immune system and may have fatal consequences.
STDs.
Intro to Microbiology & Immunology Dr. C. Rose Kyrtsos Sept. 12, 2012.
Module 4 Basic Principles of Treatment. “ubo! ubo! ubo!” (cough for 2 weeks or more) Did not take medication medication In Loving Memory of In Loving.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
Rubin_MDS218_final1 Managing Adverse Effects of HAART David Rubin, MD Clinical Assistant Professor of Medicine Weill Cornell Medical College Medical Director,
Clinical Tracking and Management of HIV-Positive Children National Pediatric HIV Training 1.
1 Antiretroviral Therapy in HIV-infected Children HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Anemia Brad Conner and Sheree Rodeffer. Why should I care? Most common blood disorder in the US –Affects 4 million It can affect anyone –Women and individuals.
Pharmacology 3 Safety and Effectiveness in Medicines Administration Applying the Evidence Base.
H1N1 Update Marty White October 12, H1N1 Information  Pandemic declared by World Health Organization in June 2009  The symptoms include fever,
WHO - PSM 14/7/2005 Principles for selection of medicines Dr Mary R. Couper Quality Assurance and Safety of Medicines WHO.
Module II: Feeding and HIV Testing for Exposed Infants This module, we will discuss: Unit 1: Infant Feeding Guidelines Unit 2: HIV Testing and Treatment.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
What Are STDs? Several of the most common STDs are often asymptomatic. Asymptomatic Individuals show no symptoms, or the symptoms are mild and disappear.
The Pregnancy Journey Open discussion. HIV and AIDS 2013 Romania Cumulative number people diagnosed with HIV since ,261 (of which 9,946 diagnosed.
Anti Retroviral Treatment Dr. Alap Mehta Senior Medical officer A.R.T. Centre.
Module 2: Learning Objectives
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
Sexually Transmitted Infections Mr. Springer 8 th Grade Health.
1 Communicating to Other Health Professionals About Your Patient: Doing Case Presentations HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Chapter 42 Care of Patients with Hematologic Problems.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Modified Essay Question
Second Line ARV: Doses & Side Effects HAIVN Harvard Medical School AIDS Initiative in Vietnam.
11 INTRODUCTION TO ANTIRETROVIRAL THERAPY (ART) IN CHILDREN: INITIATION AND MONITORING HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Side effects of antiretroviral drugs
Hepatitis B Neha Patel, Rebecca Webber, Lilimae Martin.
ALLIE PUNKE PHARMACOKINETICS: ANTIEPILEPTIC DRUGS.
CRITICAL THINKING KHUDAZI AULAWI. Critical Thinking.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Clinical Case Scenarios
Fever Ask your local pharmacist for advice on how you can manage your child’s fever.
Clinical Case Scenarios
Learning Objectives By the end of the session, participants will:
Clinical Case Scenarios
Clinical Case Scenarios
What’s New in the Perinatal Guidelines
Fever Ask your local pharmacist for advice on how you can manage your child’s fever.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Presentation transcript:

Drug Side Effects, Toxicities, and Interactions

Key Questions What are side effects and toxicities of ART? Why do we need to know the side effects and toxicities of ART? What is the management of toxicities and side effects? How do we prevent the occurrence of side effects and toxicities?

Definitions Side effects: Adverse effect: Toxicity: This refers to unwanted but natural and anticipated consequences of taking a particular medication. Such effects result from action on normal or healthy cells, tissues or organ systems other than the one for which the drug was prescribed Eg lactic acidosis due to blockage of enzyime in mitochondria, hair loss in anticancer drugs Adverse effect: Adverse reactions are rare and unforeseen bodily responses to a drug. Eg allergic reaction (NVP rash). Toxicity: This refers to the systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicitymay occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug.

Why is it important to identify toxicity effects of ARVs? Toxicity can decrease adherence, counselling is extremely important Disfiguring e.g after Steven Johnson Syndrome, Lipodystrophy Death

Side Effects and Toxicities of ARVs Please review the two charts in your Participant’s Guide: Common Side Effects of ARV Drugs (in the back of your Guide) 2. Toxicities and Side Effects of Drugs by Class (in Module IV: Side Effects Session)

Case Study Practice Let’s work in four groups to practice identifying and managing real cases of side effects, drug interactions and toxicities of ARVs.

Scenario 1 Nabatanzi is a 7 month old girl who was started on triommune baby tablets 6 days ago. Her grandmother returns today to see you because Nabatanzi has developed an itchy rash on her neck and back last evening. She is worried that it appears to be spreading even other parts of her body. She has no fever, and the rash has not formed any blisters. Her neighbour, who also has a child with HIV, has told her the rash is a sign that the drugs make the child sicker and asked her to stop them. She is confused.

Photo courtesy of Dr Israel Kalyesubula 8

Scenario 1 Which drug do you think caused the rash? Nevirapine What would you tell the grandmother? Reassure her that while the reaction may be bothersome, it does not require change of therapy. Remind her to continue monitoring the child and to report immediately if the rash gets worse and develops blistering.

Mild NVP rash Nevirapine is the commonest ARV causing skin rash as a side effect. The rash usually appears in the first 6 weeks of starting treatment To prevent nevirapine associated rash, NVP is initially given at half the full dose for the first two weeks as the health worker monitors for skin rash and signs of acute liver toxicity such as yellow eyes, abdominal pain, vomiting and lethargy Reassure the child and caregiver that while the reaction may be bothersome, it does not require change of therapy. Give symptomatic treatment. mother should continue monitoring the child and to report immediately if the rash gets worse and develops blistering 10

Scenario 2 Mbabazi is a 5 year old child who has been on Combivir, and Nevirapine for 10 days now. His concerned mother brings him to see you because he has developed peeling and ulceration of his skin and mucous membranes. His mother says his condition began as a rash all over the body and has steadily gotten worse over the last 2 days. She denies he has been burned.

Scenario 2 Which drug do you think is responsible for this clinical picture? Nevirapine How would you manage the child? Immediately discontinue all ARV drugs, manage the child as for burns Ensure the child has adequate hydration & nutrition Keep in a sterile environment, cover with antibiotics, and give pain killers. Monitor the child’s vital sign closely Answers? Answers in italics

Steven Johnson Syndrome This is a severe hypersensitivity reaction affecting the skin and the mucous membranes Can be caused by any drug. NVP is the most common ARV causing SJS, but can also be caused cotrimoxazole Immediately discontinue all ARV drugs, manage the child as for burns. Ensure the child has adequate hydration and nutrition. Keep in a sterile environment, cover with antibiotics, and give pain killers. Monitor the child’s vital sign closely. Refer patient or consult with a doctor about re-introducing ARV drugs using modified regimen when the patient has stabilized.

Scenario 3 Acayo is a 4 year old child who has been on combivir and EFV for 4 months now. She has been brought in for a routine monitoring visit. You notice that she tires easily, when she runs around your office. You also notice that her hands and conjuctiva are pale. On reviewing her labs, her baseline Hb was10mg/dl. You request for a repeat Hb, a differential count and a blood slide to rule out malaria. The Hb returns as 6.3mg/dl, the blood slide is negative, and the differential count showed a normal white cell distribution.

Scenario 3 What drug is responsible for this clinical picture? Zidovudine How would you manage this patient? Get her admitted and assessed for blood transfusion, supplement with haematinics Stop AZT and substitute with either Abacavir, Tenofovir or Stavudine Answers?

AZT induced Anaemia Zidovudine can cause severe anaemia as a side effect. Make sure the anaemia is not caused by malaria or other infectious causes Subsitute zidovudine with stavudine or tenofovir drugs. Always consult with a colleague before making the drug substitution Give folic acid or transfuse if signs of failure are present. Signs of failure include palpitation, fast heart beat and swollen feet.

Scenario 4 Kato is also on ARVs Karamagi, an 8 year old boy, has been taking his antiretroviral drugs for 3 weeks now. His older brother, Kato, 14 years, sleeps in the same room with him and has noted that: Karamagi wakes up at night screaming Describes strange dreams. Is depressed, keeps to himself and restless and irritable. Kato is also on ARVs And has developed a buffalo hump, gaunt appearance, breast tissue enlargement, tingling sensation in the feet

Which common side effects can you identify for both boys? The side effects mentioned include: Bizarre dreams/nightmares Depression Irritable Poor concentration in class Buffalo hump (lipodystrophy) Breast (lipodystrophy) Potato on a matchstick appearance (lipodystrophy) Gaunt appearance (lipoatrophy) Tingling sensation (peripheral neuropathy)

Scenario 4 Which ARV in Karamagi’s regimen could be responsible for what is being observed? Efavirenz Should Karamagi’s offending drug be substituted now? No, do not substitute it now, watch him closely and if the side effects do not disappear over the next 2 weeks or they are getting worse, substitute EFV for NVP

Scenario 4 Which ARV in Kato’s regimen could be responsible for what is being observed? Stavudine Should Kato’s drug be switched? Yes, switch to Zidovudine or Abacavir

Drug Interactions NVP and antiTB drugs (Rifampicin): Rifampicin reduces the serum levels of NVP to near sub therapeutic levels. Avoid using NVP and Rifampicin together, or increase the dose of NVP PI and antiTB drugs: Rifampicin reduces the serum levels of PI to near sub therapeutic levels. Avoid using them together Never use AZT and d4T together. They antagonize each other

Drug Toxicities NVP and cotrimoxazole are important causes of hepatitis. Other ARV drugs can cause it as well. ALT above X5 upper range is a sign of significant damage ALT > 2x UNL: should not be given nevirapine at baseline. d4T + ddI should be avoided in PLHIV with abnormal LFTs (raised ALT, AST or bilirubin). Among the NNRTs Efavirenz is the best tolerated If available: Transaminases (ALT) at baseline, after 2 weeks, four weeks, and two months on Nevirapine. Every six months if no problem.

Preventing hepatitis ALT > 2x UNL: should not be given nevirapine at baseline. d4T + ddI should be avoided in PLHA with abnormal LFTs (raised ALT, AST or bilirubin). Among the NNRTs Efavirenz is the best tolerated If available: Transaminases (ALT) at baseline, after 2 weeks, four weeks, and two months on Nevirapine. Every six months if no problem.

Management of hepatitis Stop all drugs if transaminases are more than 5 times upper limit of normal Hepatotoxic drugs should be discontinued at lower levels of LFT abnormalities if there are clinical symptoms of hepatitis. Raised ALT or AST occurs in 5-15% of people taking NNRTIs, but is symptomatic in less than 1%.